Additionally, the combination of A452 and PI synergistically reduces LMP2 and LMP7 via inhibition of the STAT3 and NF-κB in both BTZ-sensitive and BTZ-resistant MM cells. The gene discussed is NFKB1; the disease is Miyoshi myopathy.